Navigating the fine line between benefit and risk in chronic atrial fibrillation: Rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY)

Melinda J. Carrington, Jocasta Ball, John D. Horowitz, Thomas H. Marwick, Gnanadevan Mahadevan, Chiew Wong, Walter P. Abhayaratna, Brian Haluska, David R. Thompson, Paul A. Scuffham, Simon Stewart*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    14 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Navigating the fine line between benefit and risk in chronic atrial fibrillation: Rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY)'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science